Disbrow Joshua R.
SEC CIK 1566240 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AYTU | AYTU BIOPHARMA, INC | CEO, Dir | 237.2K | $223.5K | — | 9 | 2022-11-18 | 2026-07-28 |
Most active insiders at AYTU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | JAIN ABHINAV | Dir | — | — |
| 2 | PYSZCZYMUKA GREG | Chief Commercial Off | — | — |
| 3 | Donofrio John Jr. | Dir | — | — |
| 4 | Selhorn Ryan J | CFO | — | — |
| 5 | Disbrow Jarrett | Chief Business Off | — | — |
| 6 | DOCKERY CARL | Dir | — | — |
| 7 | Disbrow Joshua R. | CEO, Dir | — | — |
| 8 | LIU VIVIAN H | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 16:34 | 2026-07-28 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | A - Grant | $0.00 | +30.0K | 237.2K | +14% | $0 | |
| M | 2025-10-07 | 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | A - Grant | $0.00 | +53.9K | 207.2K | +35% | $0 |
| 2025-06-10 | 2025-06-09 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO | P - Purchase | $1.50 | +66.7K | 153.3K | +77% | +$100.0K | |
| 2025-03-03 | 2025-02-28 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO | P - Purchase | $1.30 | +15.0K | 86.6K | +21% | +$19.5K | |
| 2023-06-15 | 2023-06-14 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | P - Purchase | $1.86 | +14.0K | 71.6K | +24% | +$26.0K | |
| 2022-12-23 | 2022-12-20 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | D - Sale to Iss | $0.00 | -80.0K | 1.15M | -6% | $0 | |
| 2022-12-21 | 2022-12-19 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | P - Purchase | $0.22 | +112.4K | 1.23M | +10% | +$24.7K | |
| A | 2022-11-28 | 2022-11-18 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | P - Purchase | $0.24 | +222.0K | 1.12M | +25% | +$53.3K |
| 2022-11-21 | 2022-11-18 | AYTU | AYTU BIOPHARMA, INC | Disbrow Joshua R. | CEO, Dir | A - Grant | $0.24 | +222.0K | 1.12M | +25% | +$53.3K |
Purchase Sale Sale after option exercise All abbreviations